Tagged Articles

attorneys 652 articles

Team of lawyers to assist with lawsuits targeting opioid makers

U.S. District Judge Dan Polster approved a team of 22 lawyers to oversee the more than 180 lawsuits against companies accused of helping to fuel the national opioid epidemic. The team includes many of the same attorneys who helped land the $246 billion settlement with Big Tobacco. The proposed slate is broken down into various committees and working groups, and has room for more attorneys. The groups would be overseen by a plaintiffs steering committee, which has yet to be decided. A larger and much more detailed system for tackling the opioid litigation is needed because it is too large ... Read More

AndroGel’s label did not warn of cardiovascular risks

AbbVie Inc., never mentioned on the safety label of its testosterone replacement therapy AndroGel that users were at an increased risk of cardiovascular events, including blood clots like those that lodged in the lungs of a man suing the drug company, his attorneys said in opening arguments to an Illinois federal jury this week. Robert Nolte’s case is the third bellwether trial AbbVie has faced in a multidistrict litigation of consisting of about 7,500 cases of men alleging testosterone treatment makers did not adequately warn doctors or consumers that their products were linked to an increased risk of heart attacks, ... Read More

CVN names talc verdict No. 1 on Top 10 Most Impressive list

One woman’s trial against consumer health care giant Johnson & Johnson alleging cancer risks with the company’s talc-containing products was named the most impressive plaintiff verdict in 2017 by Courtroom View Network (CVN), a news organization that webcasts high-stakes civil trials. The news organization covered a variety of litigation to compile its Top 10 list, including bellwether product liability trials, medical malpractice trials, and complex commercial trials. The verdicts were not ranked solely by amount awarded. The news group also took into consideration the facts of each case, the parties and attorneys involved, and the potential broader impact of the ... Read More

Conductor Injured In Washington Derailment Sues Amtrak

An Amtrak conductor on a training run of the Cascades 501 that derailed in DuPont, Washington, Dec. 18 is one of the first people to sue the railroad as a result of the accident. Garrick Freeman, a 48-year-old Amtrak conductor, was among the 80 people injured when the train derailed as it sped into a downward curve at more than twice the speed limit. Thirteen of the train’s cars leaped the tracks on an overpass and landed on cars and trucks on Interstate 5 below. Three people were killed. Mr. Freeman, who was with the train’s engineer in the lead ... Read More

Primus pulls Limbrel capsules from market

Primus Pharmaceuticals Inc., is reluctantly recalling Limbrel, a capsule used to “manage the metabolic processes associated with osteoarthritis,” in response to a Food and Drug Administration (FDA) Safety Communication urging consumers not to take the medication because it has been linked to drug-induced liver injury and a lung condition called hypersensitivity pneumonitis. The agency issued a letter to James D. Weir, president and chief executive officer of Primus, requesting that the company cease distribution of the capsules and immediately recall specific lots of the drug because the agency determined that Limbrel products “represent a serious health hazard.” The FDA has ... Read More

PA schedules 17 testosterone side effects trials through January 2019

Days after Auxilium Inc., settled a lawsuit over claims its testosterone treatment caused an Alabama man to suffer a stroke, a Philadelphia Court of Common Pleas judge scheduled 17 testosterone side effects trials involving multiple testosterone makers to take place between June and January 2019. The Auxilium trial was scheduled to begin Jan. 8, and was filed in 2014. Philadelphia Court of Common Pleas Judge John M. Younge had planned to schedule seven bellwethers during that timeframe, paving the way for a settlement of the nearly 30 cases pending in the court. But instead of making good on a previous ... Read More

Alex Azar Nomination Opposed in Letter to Senate

More than 60 health care and consumer organizations have sent a letter to the U.S. Senate urging lawmakers to oppose the confirmation of Alex Azar, the former head of Eli Lily and Company’s U.S. division, to Secretary of Health and Human Services. “The undersigned organizations, representing patients, healthcare providers, public health experts, women, people of color, workers, consumers, and people of faith strongly urge you to vote against confirming Alex Azar … We are deeply concerned by statements made by Mr. Azar as well as his record at the pharmaceutical firm Eli Lilly and Company,” the letter states. The authors ... Read More

Class action certified against memory boosting supplement maker

U.S. District Judge Haywood S. Gilliam Jr., certified a class of California consumers who are accusing Quincy Bioscience LLC of falsely representing its dietary supplement Prevagen for improving memory and supporting brain function. “Because Prevagen is not marketed for uses other than improving brain health and memory, it follows that representations about these purported benefits were a ‘substantial factor’ in plaintiff’s – and all consumers’ – purchasing decision,” the court said after finding that the class meets numerosity, commonality, typicality and adequacy requirements of class action. Quincy Bioscience promoted Prevagen as being clinically tested to improve memory and support “healthy ... Read More

Talc cases moving forward in federal MDL

Attorneys for women suing Johnson & Johnson and others over claims that its talc-containing products caused ovarian cancer say there is a huge sense of urgency to move forward with the cases because of the relative deadliness of the types of cancers. “Particularly when you consider that this product has no therapeutic benefit for cosmetic uses rather than as drugs,” said Leigh O’Dell of Beasley Allen, one of the lead attorneys representing plaintiffs in the federal multidistrict litigation (MDL). More than 4,000 of lawsuits alleging injuries from Johnson & Johnson’s talc products were consolidated in federal court in the District ... Read More

Bayer tries to skirt $28M Xarelto verdict

Bayer AG is trying to wiggle out of a $28 million verdict involving Xarelto side effects by saying the plaintiff’s legal team made xenophobic and offensive statements and tried associate the German company with Nazis in the minds of jurors. Bayer Healthcare Pharmaceuticals Inc., and Johnson & Johnson unit Janssen Pharmaceuticals cited an Instagram post by plaintiff Lynn Hartman’s legal team that used the hashtag “killinnazis,” and referenced “multiple inflammatory and xenophobic references” made during closing arguments. Hartman’s case is the latest to go to trial in the Xarelto mass tort program in Philadelphia County Court of Common Pleas where ... Read More